TradingView
RocketTickers
May 14, 2020 5:15 PM

Krystal Biotech Announces Positive Interim Results from Phase 1/ Long

NASDAQ:KRYS1D
Krystal Biotech, Inc.NASDAQ

Description

⋅
KRYS: Krystal Biotech, Inc.
2020-05-14 08:00:10
Krystal Biotech Announces Positive Interim Results from Phase 1/2 Clinical Trial of KB105 in Patients with TGM1-related Autosomal Recessive Congenital Ichthyosis (ARCI)
Beyond Technical Analysis
More